Related Experiment Video
Updated: Jul 5, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
Published on: October 26, 2017
Screening and chemoprevention in lung cancer
J M Gasent Blesa1, E Esteban González, V Alberola Candel
1Dpto. Oncología Médica, Hospital General Universitario Marina Alta, Dènia, Alacant, Spain. joanmagasent@telefonica.net
Abstract:
Lung cancer is a major health problem due to its incidence and mortality. The risk factors, the existence of a preclinical phase, and the relationship between stage at diagnosis and survival are known. A number of strategies that aim to diagnose lung cancer in its earliest stages, based principally on imaging studies, are therefore being tested. Several drugs aimed at reducing the probability of developing lung cancer in the at-risk population are also under study. At the present time, the results obtained have not been encouraging and we do not have a clear strategy either for early diagnosis or for the use of chemopreventive agents.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Preventive Healthcare Services
Targeted Cancer Therapies
There are several types of targeted therapies against specific...